Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | IKBKB | O14920 | 1/20 | 0.35 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9722911 | 0.84 | IKBKB (0.38) | MAPTKMT2AHTTMEN1IKBKB | |
| SCHEMBL10481312 | 0.81 | ALDH1A1 (0.38) | MAPTKMT2AIKBKBCLCN2SMN1; SMN2 | |
| SCHEMBL27731731 | 0.79 | HSP90AB1 (0.43) | MAPTKMT2AHTTMEN1IKBKB | |
| SCHEMBL9722967 | 0.77 | ALDH1A1 (0.42) | MAPTHTTIKBKBCLCN2NPC1 | |
| SCHEMBL9744146 | 0.77 | KDM4E (0.58) | FFAR4MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3810854 | 0.76 | CLCN2 (0.52) | MAPTKMT2AMEN1IKBKBCLCN2 | |
| SCHEMBL9722960 | 0.74 | MRGPRX1 (0.37) | MAPTKMT2AIKBKBCLCN2SMN1; SMN2 | |
| SCHEMBL9722931 | 0.73 | CES2 (0.44) | HTTIKBKBCLCN2CES2CES1 | |
| SCHEMBL6535624 | 0.72 | IKBKB (0.36) | MAPTHTTIKBKBCLCN2SMN1; SMN2 | |
| SCHEMBL10631588 | 0.72 | KMT2A (0.38) | MAPTKMT2AIKBKBCLCN2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070010676-A1 | Stereospecific enrichment of heterocyclic enantiomers | R.T. ALAMO VENTURES I, LLC | 2007-01-11 | — | — | US | disclosed |
| US-20070010552-A1 | Fluorinated heterocyclic compounds and methods of synthesis | R.T. ALAMO VENTURES I, LLC | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010676-A1 | Stereospecific enrichment of heterocyclic enantiomers | CBR3, CBR1, QDPR | FFAR4 1056/4885MAPT 4853/4885KMT2A 3308/4885 |
| US-20070010552-A1 | Fluorinated heterocyclic compounds and methods of synthesis | FDPS, PFAS, AFF4 | FFAR4 1268/4885MAPT 4164/4885KMT2A 1236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.